| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5644012 | The Surgeon | 2017 | 6 Pages |
Abstract
Patients with TNBC have adverse outcomes despite aggressive treatment. The development of effective targeted therapies is essential for this breast cancer subtype.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Dentistry, Oral Surgery and Medicine
Authors
D.P. Joyce, D. Murphy, A.J. Lowery, C. Curran, K. Barry, C. Malone, R. McLaughlin, M.J. Kerin,